Literature DB >> 2343353

Cysticercal meningitis--a pernicious form of neurocysticercosis which responds poorly to praziquantel.

J Joubert1.   

Abstract

Chronic cysticercal meningitis was diagnosed in 6 of 260 cases of neurocysticercosis. Clinical features usually associated with meningitis, such as fever, cranial nerve palsies and nuchal rigidity, were absent and the diagnosis was reached because of persistently abnormal cerebrospinal fluid (CSF) associated with active neurocysticercosis on computed tomography. Other causes of chronic meningitis were excluded. Hydrocephalus, either obstructive or communicating, was present in all 6 patients. The results of medical treatment with praziquantel were poor and there was no improvement either clinically or in the CSF. Severe clinical sequelae, such as dementia, blindness and gait ataxia, were common despite protracted medical treatment and ventriculoperitoneal shunting.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2343353

Source DB:  PubMed          Journal:  S Afr Med J


  5 in total

Review 1.  Extraparenchymal (Racemose) Neurocysticercosis and Its Multitude Manifestations: A Comprehensive Review.

Authors:  Rohan R Mahale; Anish Mehta; Srinivasa Rangasetty
Journal:  J Clin Neurol       Date:  2015-05-28       Impact factor: 3.077

2.  Acute cysticercal meningitis--missed diagnosis.

Authors:  Devendra Mishra; Suvasini Sharma; Sanjeev Gupta; Manoja Das; Dinesh Chauhan
Journal:  Indian J Pediatr       Date:  2006-09       Impact factor: 1.967

3.  Multilevel intramedullary spinal neurocysticercosis with eosinophilic meningitis.

Authors:  Amir M Torabi; Mary Quiceno; Dianne B Mendelsohn; Craig M Powell
Journal:  Arch Neurol       Date:  2004-05

4.  Severe cysticercal meningitis: clinical and imaging characteristics.

Authors:  Graciela Cárdenas; Helgi Jung; Camilo Ríos; Agnes Fleury; José Luís Soto-Hernández
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

Review 5.  Psychiatric Disorders of Neurocysticercosis: Narrative Review.

Authors:  Asmaa M El-Kady; Khaled S Allemailem; Ahmad Almatroudi; Birgit Abler; Mohamed Elsayed
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-25       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.